Healthcare news, data and analysis
Via Investors in Healthcare
Switzerland: Granite Bio emerges from stealth with US$100m in funding
Granite Bio, a Switzerland-based clinical-stage immunology company, has emerged from stealth with US$100m in funding, which includes a US$30m Series A led by founding investors Versant Ventures and Novartis Venture […]
Granite Bio, a Switzerland-based clinical-stage immunology company, has emerged from stealth with US$100m in funding, which includes a US$30m Series A led by founding investors Versant Ventures and Novartis Venture […]
Switzerland: Granite Bio emerges from stealth with US$100m in funding
April 25, 2025
News
Pharma
Venture
Eliot Forster
Forbion
UK: Abigail Badà returns to CCO to lead People and Culture practice
Compass Carter Osborne (CCO), a provider of executive search and advisory services to the investment community within health, care, and life sciences sectors, has announced the return of Abigail Badà, […]
Compass Carter Osborne (CCO), a provider of executive search and advisory services to the investment community within health, care, and life sciences sectors, has announced the return of Abigail Badà, […]
UK: Abigail Badà returns to CCO to lead People and Culture practice
April 24, 2025
Consumer Healthcare
Cosmetic & Aesthetics
Healthcare
News
Staffing
Switzerland: Voyager Acquisition Corp combines with Veraxa for Nasdaq IPO
Veraxa Biotech, a drug discovery and development engine for antibody-drug conjugates (ADCs) and novel antibody-based therapy concepts, and Voyager Acquisition Corp, a US$253m Nasdaq-listed SPAC targeting the healthcare sector, are […]
Veraxa Biotech, a drug discovery and development engine for antibody-drug conjugates (ADCs) and novel antibody-based therapy concepts, and Voyager Acquisition Corp, a US$253m Nasdaq-listed SPAC targeting the healthcare sector, are […]
Switzerland: Voyager Acquisition Corp combines with Veraxa for Nasdaq IPO
April 24, 2025
Buy Out
Life Sciences
M&A
Manufacturing – Specialty Pharma
News
One of the largest preclinical ADC deals: Taiho Pharma’s US$1.14bn acquisition of Araris Biotech
In March, Taiho Pharmaceutical announced its planned acquisition of Switzerland-based Araris Biotech, a company developing next-generation antibody drug conjugates (ADCs), in one of the largest ever preclinical ADC acquisitions. The transaction underscores the […]
In March, Taiho Pharmaceutical announced its planned acquisition of Switzerland-based Araris Biotech, a company developing next-generation antibody drug conjugates (ADCs), in one of the largest ever preclinical ADC acquisitions. The transaction underscores the […]
One of the largest preclinical ADC deals: Taiho Pharma’s US$1.14bn acquisition of Araris Biotech
April 24, 2025
Analysis
Life Sciences
Manufacturing – Specialty Pharma
News
Pharma
Sweden: Biotage recommends shareholders accept KKR’s SEK11.607bn public takeover offer
RWK Bidco, a company owned by KKR, has made a cash offer of SEK145 per share for Nasdaq Stockholm-listed biotechnology company Biotage. The board has recommended that shareholders accept the […]
RWK Bidco, a company owned by KKR, has made a cash offer of SEK145 per share for Nasdaq Stockholm-listed biotechnology company Biotage. The board has recommended that shareholders accept the […]
Sweden: Biotage recommends shareholders accept KKR’s SEK11.607bn public takeover offer
April 24, 2025
Buy Out
M&A
News
Pharma
Public Equity
Poland: CVC Credit provides debt facilities to American Heart of Poland
CVC Credit, the dedicated credit arm of PE firm CVC, has provided debt facilities to American Heart of Poland (AHP), Poland’s largest privately operated cardiology provider. AHP is owned by […]
CVC Credit, the dedicated credit arm of PE firm CVC, has provided debt facilities to American Heart of Poland (AHP), Poland’s largest privately operated cardiology provider. AHP is owned by […]
Poland: CVC Credit provides debt facilities to American Heart of Poland
April 23, 2025
Clinical Labs
Debt
Healthcare
Hospitals and Clinics
News
The Netherlands: Boehringer Ingelheim gains exposure to ALTs through Tessellate Bio partnership
Germany-based Boehringer Ingelheim, the world’s largest private pharma, and Tessellate Bio, a precision oncology company with a focus on developing novel synthetic lethality approaches, have entered into a research collaboration […]
Germany-based Boehringer Ingelheim, the world’s largest private pharma, and Tessellate Bio, a precision oncology company with a focus on developing novel synthetic lethality approaches, have entered into a research collaboration […]
The Netherlands: Boehringer Ingelheim gains exposure to ALTs through Tessellate Bio partnership
April 23, 2025
News
Pharma
Andree Blaukat
BioGeneration Ventures (BGV)
Boehringer Ingelheim
Italy: Claris Ventures launches Biotech II – a new VC fund for Italian biotech
Early-stage biotech investors Claris Ventures, a VC firm based in Turin, has announced the first closing of Claris Biotech II, a venture capital fund dedicated to early-stage investments in biotech […]
Early-stage biotech investors Claris Ventures, a VC firm based in Turin, has announced the first closing of Claris Biotech II, a venture capital fund dedicated to early-stage investments in biotech […]
Italy: Claris Ventures launches Biotech II – a new VC fund for Italian biotech
April 23, 2025
News
People
Pharma
Venture
Ciro Spedaliere
Switzerland: Ypsomed to sell diabetes business to TecMed for up to CHF420m
TecMed has entered into an agreement to acquire the Ypsomed Diabetes Care business of SIX-listed Ypsomed for up to CHF420m (US$517m), including earn-out. TecMed is a Burgdorf-based company controlled by […]
TecMed has entered into an agreement to acquire the Ypsomed Diabetes Care business of SIX-listed Ypsomed for up to CHF420m (US$517m), including earn-out. TecMed is a Burgdorf-based company controlled by […]
Switzerland: Ypsomed to sell diabetes business to TecMed for up to CHF420m
April 22, 2025
Life Sciences
M&A
Medtech – Medical Devices and Implants
News
IFBC
Spain: Pere Mañé takes up CEO role at Suanfarma
Archimed portfolio company, Suanfarma, a Spain-based global company specializing in the development, production, and commercialization of APIs and CDMO services for the health industry, has announced the appointment of Pere Mañé Godina as […]
Archimed portfolio company, Suanfarma, a Spain-based global company specializing in the development, production, and commercialization of APIs and CDMO services for the health industry, has announced the appointment of Pere Mañé Godina as […]
Spain: Pere Mañé takes up CEO role at Suanfarma
April 22, 2025
News
Pharma
Services – CRO/CMO/CDMO
ArchiMed
Carlos Alonso
Ireland: Investindustrial agrees acquisition of DCC’s healthcare division for £1.05bn
Healthco Investment (an independently managed investment subsidiary of funds managed and/or advised by Investindustrial Advisors) has agreed to acquire DCC Healthcare, the healthcare division of DCC, an Irish-incorporated, UK-listed company […]
Healthco Investment (an independently managed investment subsidiary of funds managed and/or advised by Investindustrial Advisors) has agreed to acquire DCC Healthcare, the healthcare division of DCC, an Irish-incorporated, UK-listed company […]
Ireland: Investindustrial agrees acquisition of DCC’s healthcare division for £1.05bn
April 22, 2025
Buy Out
M&A
News
Pharma
Services – CRO/CMO/CDMO
Germany: Goodwin advises Gimv on financing of Unizell acquisition and Medi-Markt refinancing
The Private Equity/Finance team at the German operation of global law firm Goodwin advised Gimv on the financing of the acquisition of Unizell Medicare and its subsidiaries and the refinancing […]
The Private Equity/Finance team at the German operation of global law firm Goodwin advised Gimv on the financing of the acquisition of Unizell Medicare and its subsidiaries and the refinancing […]
Germany: Goodwin advises Gimv on financing of Unizell acquisition and Medi-Markt refinancing
April 21, 2025
Buy Out
Homecare
M&A
News
Social Care
UK: Leadership changes at Pharmanovia
Pharmanovia, a global lifecycle management healthcare company, has confirmed that James Burt, is stepping down from the role of CEO. Founder, Amit Patel and COO, Sagar Patel has assumed the […]
Pharmanovia, a global lifecycle management healthcare company, has confirmed that James Burt, is stepping down from the role of CEO. Founder, Amit Patel and COO, Sagar Patel has assumed the […]
UK: Leadership changes at Pharmanovia
April 17, 2025
People
Pharma
David Murray
Guido Oelkers
James Burt
Spain: DomusVi sells Spanish mental health division to Neural
Spain-based European senior care, housing and services company DomusVi, is selling its Spanish mental health subsidiary, Mentalia Salud, to Neural, a Spain neurorehabilitation company backed by UK-based Peninsula Capital Advisors. […]
Spain-based European senior care, housing and services company DomusVi, is selling its Spanish mental health subsidiary, Mentalia Salud, to Neural, a Spain neurorehabilitation company backed by UK-based Peninsula Capital Advisors. […]
Spain: DomusVi sells Spanish mental health division to Neural
April 17, 2025
Buy Out
Healthcare
M&A
Mental Health
News
UK: Juvenescence receives strategic investment from M42
UK-based Juvenescence, a clinical-stage AI-enabled biotech company developing novel medicines to extend healthy lifespan, has received a strategic investment from Abu Dhabi-based M42, a tech-enabled integrated healthcare company created through […]
UK-based Juvenescence, a clinical-stage AI-enabled biotech company developing novel medicines to extend healthy lifespan, has received a strategic investment from Abu Dhabi-based M42, a tech-enabled integrated healthcare company created through […]
UK: Juvenescence receives strategic investment from M42
April 17, 2025
Manufacturing – Specialty Pharma
News
Pharma
Venture
Hasan Jasem Al Nowais
UK: Meribel Pharma Solutions launches with ambition to elevate pharma services
Meribel Pharma Solutions, a new, mid-size CDMO, has been launched with an integrated network across Europe, on a mission to deliver high quality solutions and services. The firm has 13 manufacturing […]
Meribel Pharma Solutions, a new, mid-size CDMO, has been launched with an integrated network across Europe, on a mission to deliver high quality solutions and services. The firm has 13 manufacturing […]
UK: Meribel Pharma Solutions launches with ambition to elevate pharma services
April 17, 2025
News
Pharma
Services – CRO/CMO/CDMO
Blue Wolf Capital Partners
Bruce Vielle
UK: Ansor closes Fund II at hard cap of £250m in oversubscribed fundraise
Ansor, a UK-based ground-up buy-and-build investor, has held the final close of its second fund, Ansor Fund II, at its hard cap of £250m (US$332m) – and approximate doubling in […]
Ansor, a UK-based ground-up buy-and-build investor, has held the final close of its second fund, Ansor Fund II, at its hard cap of £250m (US$332m) – and approximate doubling in […]
UK: Ansor closes Fund II at hard cap of £250m in oversubscribed fundraise
April 16, 2025
Dental
Healthcare
Life Sciences
M&A
Medtech – Hospital Equipment
Europe: Tom Hamer of Kilburn & Strode outlines compliance challenges and responsibilities from EU AI Act
As of February 2, AI systems that represent an “unacceptable risk” became prohibited in the EU. For companies operating in the medical device sector, the EU AI Act introduces new […]
As of February 2, AI systems that represent an “unacceptable risk” became prohibited in the EU. For companies operating in the medical device sector, the EU AI Act introduces new […]
Europe: Tom Hamer of Kilburn & Strode outlines compliance challenges and responsibilities from EU AI Act
April 16, 2025
Analysis
Legal
Life Sciences
Medtech – Diagnostics
Medtech – Healthcare IT
UK: Ben Betts appointed as new CEO at Agilio Software
Agilio Software, a UK-based provider of healthcare operations software, has appointed Dr Ben Betts as its new CEO. Agilio is acquired by backed by strategic growth investment from Five Arrows, […]
Agilio Software, a UK-based provider of healthcare operations software, has appointed Dr Ben Betts as its new CEO. Agilio is acquired by backed by strategic growth investment from Five Arrows, […]
UK: Ben Betts appointed as new CEO at Agilio Software
April 16, 2025
Digital Health/Healthtech
Healthcare
People
Agilio Software
Ben Betts
France: Five Arrows secures €2bn in commitments for latest secondary opportunities fund
Five Arrows, the alternative assets arm of Rothschild & Co, has completed fundraising for Secondary Opportunities VI, its sixth fund focused on GP-led secondary investments, securing total capital commitments of €2bn […]
Five Arrows, the alternative assets arm of Rothschild & Co, has completed fundraising for Secondary Opportunities VI, its sixth fund focused on GP-led secondary investments, securing total capital commitments of €2bn […]
France: Five Arrows secures €2bn in commitments for latest secondary opportunities fund
April 15, 2025
Buy Out
Healthcare
News
Benjamin Breard
Five Arrows
France: Mérieux Equity Partners sells stake in Theravia to Norgine
Mérieux Equity Partners (MxEP) has signed an agreement Norgine, a European specialist pharmaceutical company, to sell its majority stake in the French company Theravia. “This acquisition is a unique opportunity […]
Mérieux Equity Partners (MxEP) has signed an agreement Norgine, a European specialist pharmaceutical company, to sell its majority stake in the French company Theravia. “This acquisition is a unique opportunity […]
France: Mérieux Equity Partners sells stake in Theravia to Norgine
April 15, 2025
Buy Out
M&A
Manufacturing – Specialty Pharma
News
Pharma
Belgium: Nicolas Darnaud leaves Ardian after 12 years for Cobepa
Nicolas Darnaud has joined Cobepa, an independent, privately held investment company with offices in Brussels and New York. Before joining Cobepa, Darnaud was at France-based Ardian (formerly Axa Private Equity) […]
Nicolas Darnaud has joined Cobepa, an independent, privately held investment company with offices in Brussels and New York. Before joining Cobepa, Darnaud was at France-based Ardian (formerly Axa Private Equity) […]
Belgium: Nicolas Darnaud leaves Ardian after 12 years for Cobepa
April 15, 2025
Healthcare
People
Ardian
Belgium
Cobepa
Switzerland: Healthcare Holding Switzerland strengthens portfolio with Schaublin Medica
Healthcare Holding Switzerland, a provider of services and distributor of medical technology in Switzerland, has strengthened its portfolio with the acquisition of Schaublin Medica, a specialized distributor in cardiac and […]
Healthcare Holding Switzerland, a provider of services and distributor of medical technology in Switzerland, has strengthened its portfolio with the acquisition of Schaublin Medica, a specialized distributor in cardiac and […]
Switzerland: Healthcare Holding Switzerland strengthens portfolio with Schaublin Medica
April 15, 2025
Buy Out
Life Sciences
M&A
Medtech – Hospital Equipment
Medtech – Medical Devices and Implants
IIH talks to Philipp Ziehr on 1Q Health’s ambition to become one of Europe’s top 20 CDMOs
1Q Health, a European CDMO focusing on premium pharmaceuticals and nutraceutical supplements, is a relatively new name to the pharma service sector. Operating under the motto “Fast Track to Quality”, […]
1Q Health, a European CDMO focusing on premium pharmaceuticals and nutraceutical supplements, is a relatively new name to the pharma service sector. Operating under the motto “Fast Track to Quality”, […]
IIH talks to Philipp Ziehr on 1Q Health’s ambition to become one of Europe’s top 20 CDMOs
April 14, 2025
Analysis
Articles
Pharma
Services – CRO/CMO/CDMO
1Q Health Group
Sweden: Pär Ihrskog to join Vitrolife Group as CFO
Pär Ihrskog has been appointed CFO of Vitrolife Group, the Gothenburg-based developer and manufacturer of products for assisted reproduction, effective October 10, 2025. Ihrskog joins from Bufab Group where he currently […]
Pär Ihrskog has been appointed CFO of Vitrolife Group, the Gothenburg-based developer and manufacturer of products for assisted reproduction, effective October 10, 2025. Ihrskog joins from Bufab Group where he currently […]
Sweden: Pär Ihrskog to join Vitrolife Group as CFO
April 11, 2025
Fertility
Healthcare
Life Sciences
Medtech – Medical Devices and Implants
People
Our Sectors
We are experts at what we do
01
Our People
A dedicated team of executive search experts, delivering for you
The Compass Carter Osborne team are healthcare and life science experts. As a trusted advisor we bring decades of search experience and an unparalleled track record of delivery across our dedicated sectors for our investor clients – relied upon time and again to build outstanding leadership teams.
Familiar faces at key industry events, our expertise extends beyond the mere placing of people with our consultants bringing together sector leaders to address key challenges, working in partnership to produce tangible solutions.
02
Expertise
Unearthing rare talent, that drive successful exits
Responsive, adaptable, and emotionally intelligent, Compass Carter Osborne avoid the one-size-fits-all approach to ensure our clients achieve their desired outcome by presenting a broad range of intuitive, tailored solutions, based on specific needs.
03
Our Approach
Tailoring our offering,
to provide a bespoke service
Results driven, not process led, CCO avoid the conformity of a rigid process. Never assumptive, we listen and adopt an agreed approach which most closely delivers to a clients specific needs. Understanding the uniqueness of each role, our people tailor a search to bespoke requirements to ensure solutions that delivers the best possible results first time, every time.
A trusted advisor to the investment community
providing leaders advancing the healthcare and life sciences sectors
What our clients say
“Compass Carter Osborne really delivered for us in our search for a new CEO for Outcomes First Group. It was a vitally important assignment given that we were recruiting a successor for a long standing and highly successful CEO in a sector-leading business. Compass Carter Osborne went above and beyond in developing a deep understanding of the business and our requirements, and in only presenting candidates that closely met these. They think very creatively and their focus was very sharp; they particularly understood the culture of the business. The search was speedy and well organised, with a very high standard of verbal and written feedback. They have a granular knowledge of the sector and because of the way in which they work, we were fully involved throughout and achieved a great result. A really excellent search – thank you.”
Outcomes First Group – Chair
“Compass Carter Osborne started from the very beginning with a detailed, professional explanation of the available position. They spent time to present the great opportunity and chance to accelerate my career but at the same time, the challenge, and the strong expectation from their client.”
Hengrui Therapeutics – VP, Head Biological Drug Discovery
“Compass Carter Osborne delivered on a key appointment for the PFA and the wider football industry. It was a complex brief involving creating an entirely new position. The role was vitally important, with the successful candidate taking on a sensitive and multifaceted responsibility across CTE, concussion and brain health in professional football. CCO led a comprehensive and exhaustive process, developing a deep understanding of the union’s requirements and using his expert knowledge to help scope and evolve the brief throughout the search. The entire process was professional, efficient and well organised, with consistent communication and feedback at every stage.”
The Professional Footballers Association (PFA) – Chief Executive Officer
“I have been so impressed by Luke’s integrity, clear purpose and drive to achieve for his clients. Luke has worked with Priory on a number of things but more recently to source two independent Non Executive Directors and a Director of Talent Acquisition. He has kept us informed, fielded some great candidates and follows up at each stage, even when they have started. I would really recommend him if you are searching for high calibre individuals.”
Priory Group – Chief Executive Officer
“I recently had the pleasure of being appointed to an independent healthcare provider as a NED after being put forward for the role by Luke. Throughout the whole recruitment process I was treated with respect and felt valued. I was particularly impressed with the follow up support after the decision to appoint me, which I have never experienced from other search companies. Luke continued to check in with me to ensure my onboarding went smoothly and that I had settled into the role. Overall, a highly professional and comprehensive approach delivered personally by Luke.”
Priory – Independent Non-Executive Director
“Luke was absolutely brilliant along the journey. He acted as a real partner and was able to answer to all my questions in order to get comfortable with the decision of making the change. His expertise and knowledge of the sector really came out along the process. Most importantly, he was always available when I needed him to be, which is something I valued a lot. In summary, I couldn’t recommend him and Compass Carter Osborne enough.”
AniCura – Group Chief Operating Officer
“We worked with Compass Carter Osborne in the search for our Chief Financial Officer and from the start it was clear they were a good choice of partner. A focus on understanding our needs as a business, and mine personally as a CEO were front of mind for Paul and Kieran. They took the time to listen, understand and not only focus on the functional aspects of the role – but critically, the team fit and culture we are building.
Process, structure and follow-through were like clockwork, and the quality of candidates were of a consistently high-level. I would highly recommend Compass Carter Osborne.”
Renaiss Health – Chief Executive Officer
“I’ve known Tarquin for over 15 years, during which time he has delivered a number of executive assignments at senior level, including COO/executive team and senior management roles in scientific/professional disciplines (his network in the biotech/life-sciences sector is second-to-none!). He works hard to truly understand both the candidate brief and the culture of the company, sets realistic expectations and retains regular contact as an assignment progresses, always providing thorough updates and pragmatic advice. He has the highest levels of professionalism and integrity – he really is a pleasure to work with.”
One Nucleus – Director
“Jamie did a great job – he really took the time to understand our business, our needs and what we were looking for. We knew our brief was specific, yet Jamie met all our expectations with the search. He maintained a high standard of communication and meticulous attention to detail throughout the process. I would recommend Jamie and the Compass Carter Osborne team without hesitation.”
Melrose Education – Chair & CEO
“Our recent work with Compass Carter Osborne was exceptional. The search was perfectly organised, response times were swift, and due to the consultant market knowledge and network, we quickly found our ideal candidate.”
Schoen Clinic – Member of Group Executive
